Double maintains 4 strategies that include RARE - Ultragenyx Pharmaceutical, Inc.
Yahoo
We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at where Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) stands against the other best mid cap biotech stocks to buy. Is the Biotech Sector Oversaturated? On March 6, Jared Holz, Mizuho health care […]
Yahoo
NOVATO, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today reported the grant of 21,806 restricted stock units of the company’s common stock to 16 newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company’s board of directors and granted under the Ultragenyx Empl
Yahoo
Piper Sandler lowered the firm’s price target on Ultragenyx (RARE) to $115 from $140 and keeps an Overweight rating on the shares after analyst coverage transfer. The firm says that while this name boasts a strong commercial business, Piper notes a collection of high value, relatively low risk assets with appropriate balance across early, mid- and late-stage development. Several key clinical and regulatory catalysts are on tap, most near-term and top of mind being the second interim analysis of
SeekingAlpha
Baker Brothers' 13F portfolio value decreased from $9.65B to $9.36B. Check out the portfolio's top holdings and notable stake increases.
SeekingAlpha
The ClearBridge SMID Cap Growth Strategy outperformed its Russell 2500 Growth Index benchmark during the fourth quarter. Click here to read the full commentary.
Yahoo
NOVATO, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultrarare genetic diseases, today announced participation in three upcoming investor conferences. 45th Annual Cowen Healthcare Conference (Boston, MA) Monday, March 3, 2025, Eric Crombez, M.D., Chief Medical Officer, will participate in a fireside chat and host 1x1 meetings. Barclays 2
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BOOM | 0.01% | $170.44M | -56.42% | 0.00% |
KOF | -0.01% | $4.79B | -5.07% | 4.46% |
AMR | 0.02% | $1.63B | -61.48% | 0.00% |
TKC | -0.02% | $5.42B | +21.01% | 3.29% |
HQY | -0.04% | $7.64B | +8.26% | 0.00% |
LTM | -0.04% | $9.45B | -100.00% | <0.01% |
EQT | -0.05% | $31.92B | +43.98% | 1.18% |
CRK | 0.07% | $5.96B | +118.24% | 0.00% |
MGY | -0.11% | $4.90B | -3.55% | 2.14% |
BVN | -0.11% | $3.97B | +1.56% | 0.00% |
CLB | 0.13% | $701.93M | -12.49% | 0.27% |
COR | 0.13% | $53.93B | +14.44% | 0.76% |
PSQH | 0.13% | $98.27M | -53.36% | 0.00% |
TK | 0.14% | $548.85M | +0.75% | 0.00% |
AWH | 0.14% | $1.66M | -96.86% | 0.00% |
SEG | 0.16% | $272.60M | -16.63% | 0.00% |
NNE | 0.17% | $980.95M | +561.50% | 0.00% |
CORT | 0.24% | $12.05B | +343.75% | 0.00% |
RRC | -0.27% | $9.64B | +14.71% | 0.83% |
USM | -0.32% | $5.88B | +92.67% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CHD | -10.71% | $27.09B | +4.83% | 1.03% |
VZ | -10.47% | $190.95B | +7.28% | 5.89% |
PPC | -10.21% | $12.93B | +57.95% | 0.00% |
SSL | -9.80% | $2.66B | -45.42% | 0.00% |
BTCT | -9.74% | $20.20M | +17.54% | 0.00% |
HEES | -9.72% | $3.47B | +50.53% | 1.16% |
KR | -8.81% | $48.98B | +18.78% | 1.86% |
SAFT | -8.08% | $1.17B | -2.70% | 4.56% |
HUSA | -7.80% | $12.08M | -45.38% | 0.00% |
T | -6.88% | $203.00B | +61.60% | 3.91% |
LITB | -6.69% | $36.77M | -56.14% | 0.00% |
PGR | -6.17% | $165.90B | +34.80% | 1.73% |
CQP | -5.76% | $31.97B | +33.68% | 4.87% |
TCTM | -5.65% | $3.39M | -83.19% | 0.00% |
TR | -5.43% | $2.25B | +2.19% | 1.14% |
CNP | -5.30% | $23.61B | +27.48% | 2.29% |
DK | -5.22% | $932.32M | -50.93% | 6.76% |
EXC | -5.07% | $46.52B | +23.77% | 3.35% |
NEUE | -4.79% | $58.51M | +7.28% | 0.00% |
ULS | -4.76% | $11.29B | +101.43% | 0.90% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 54.06% | $5.33B | 0.35% |
GNOM | 53.23% | $53.29M | 0.5% |
IBB | 49.79% | $5.92B | 0.45% |
PINK | 47.72% | $141.43M | 0.5% |
BBH | 45.99% | $368.79M | 0.35% |
PTH | 45.59% | $110.42M | 0.6% |
PBE | 43.16% | $233.11M | 0.58% |
FBT | 42.99% | $1.08B | 0.56% |
ARKG | 42.16% | $977.87M | 0.75% |
XPH | 40.72% | $156.75M | 0.35% |
FXH | 40.72% | $960.13M | 0.62% |
VHT | 39.51% | $16.42B | 0.09% |
FHLC | 39.11% | $2.69B | 0.084% |
QQQJ | 37.41% | $594.32M | 0.15% |
IXJ | 36.79% | $3.93B | 0.41% |
AOM | 36.77% | $1.45B | 0.15% |
IYH | 36.71% | $3.18B | 0.39% |
KJUL | 36.45% | $155.38M | 0.79% |
IHE | 36.07% | $600.56M | 0.39% |
VBK | 35.91% | $17.51B | 0.07% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BUXX | -0.14% | $231.44M | 0.25% |
TBLL | 0.17% | $2.07B | 0.08% |
KCCA | 0.22% | $109.47M | 0.87% |
KBA | 0.35% | $198.48M | 0.56% |
JMST | 0.37% | $3.55B | 0.18% |
AFIF | -0.46% | $135.76M | 1.11% |
CNYA | -0.64% | $219.11M | 0.6% |
BOXX | 0.72% | $5.72B | 0.1949% |
ASHR | -0.79% | $2.65B | 0.65% |
BIL | -0.90% | $41.08B | 0.1356% |
MINT | 0.91% | $13.27B | 0.35% |
UNG | -0.95% | $434.44M | 1.06% |
COM | 1.21% | $241.04M | 0.72% |
KRBN | -1.28% | $173.49M | 0.85% |
TUR | 1.45% | $184.69M | 0.59% |
CCOR | 1.49% | $64.35M | 1.18% |
FTGC | 1.60% | $2.50B | 1.02% |
WEAT | 1.68% | $113.78M | 0.28% |
ULST | 1.96% | $587.03M | 0.2% |
BSSX | 2.10% | $75.46M | 0.18% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -24.95% | $404.97M | 1.43% |
USDU | -23.10% | $213.46M | 0.5% |
UUP | -22.27% | $327.80M | 0.77% |
TPMN | -22.14% | $33.51M | 0.65% |
VIXY | -18.23% | $195.31M | 0.85% |
CLOZ | -16.02% | $817.63M | 0.5% |
USFR | -13.75% | $18.41B | 0.15% |
TAIL | -13.15% | $86.92M | 0.59% |
JAAA | -11.03% | $21.40B | 0.21% |
DBE | -10.78% | $54.58M | 0.77% |
CTA | -10.34% | $963.19M | 0.76% |
JBBB | -10.30% | $1.74B | 0.49% |
FLTR | -9.88% | $2.42B | 0.14% |
UGA | -9.28% | $88.11M | 0.97% |
USL | -9.24% | $46.60M | 0.85% |
DBO | -8.31% | $197.54M | 0.77% |
BNO | -8.14% | $95.40M | 1% |
OILK | -8.07% | $66.42M | 0.69% |
USO | -7.70% | $1.02B | 0.6% |
BILZ | -7.17% | $709.48M | 0.14% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CRNX | 43.55% | $3.12B | -27.92% | 0.00% |
RVMD | 41.22% | $6.57B | +11.62% | 0.00% |
IONS | 39.45% | $4.80B | -31.34% | 0.00% |
DNLI | 39.13% | $1.97B | -33.88% | 0.00% |
RNA | 38.34% | $3.55B | +11.82% | 0.00% |
COGT | 37.54% | $681.96M | -13.19% | 0.00% |
ARWR | 37.39% | $1.75B | -54.89% | 0.00% |
NCZ | 36.01% | - | - | 4.68% |
NTLA | 35.72% | $736.01M | -73.88% | 0.00% |
KRYS | 35.67% | $5.19B | +2.40% | 0.00% |
RCKT | 35.55% | $711.22M | -75.04% | 0.00% |
DASH | 34.90% | $76.78B | +32.20% | 0.00% |
CERS | 34.60% | $258.25M | -22.78% | 0.00% |
BFAM | 34.58% | $7.29B | +12.93% | 0.00% |
IDYA | 34.38% | $1.43B | -61.48% | 0.00% |
NCV | 34.34% | - | - | 4.72% |
ROIV | 34.27% | $7.20B | -3.26% | 0.00% |
NTRA | 33.27% | $19.12B | +52.12% | 0.00% |
KYMR | 33.03% | $1.78B | -30.57% | 0.00% |
MIRM | 33.01% | $2.21B | +77.01% | 0.00% |
Current Value
$36.061 Year Return
Current Value
$36.061 Year Return